Melanocortin 2 Receptor therapy (OMass Therapeutics)

N/A

Report date: 2024/09/14 11:38:28
NME

Base Information

Drug NameMelanocortin 2 Receptor therapy (OMass Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 2 modulators
TargetsMelanocortin receptor 2
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOMass Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOMass Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsEndocrine System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A